CD274 and neoplasm: Nowadays, programmed death receptor ligand 1 (PD-L1) is the most studied immune checkpoint molecule, which promotes immunosuppression by binding to PD-1 on T-cells in tumor immunity, and it already plays a crucial role in muscle-invasive bladder cancers (MIBC) treatment [3,4].